Skip to main content
. 2021 Jan 22;112(3):1026–1037. doi: 10.1111/cas.14796

FIGURE 5.

FIGURE 5

IHC analysis of human gastric cancer (GC) tissue. A, IHC staining of non‐cancerous gastric epithelia with the ANO9 antibody. Magnification: ×100. B, IHC staining of primary human GC samples with the ANO9 antibody. Magnification: ×100. The IHC of ANO9 are results shown with low expression (C) and high expression (D). Magnification: ×400. E, All patients were classified into 2 groups: a low ANO9 expression group (<1.8, n = 53, blue line) and high ANO9 expression group (≥1.8, n = 31, red line). *P < .05 (significant difference). F, IHC staining of non‐cancerous gastric epithelia with the PD‐L2 antibody. Magnification: ×100. G, IHC staining of primary human GC samples with the ANO9 antibody. Magnification: ×100. IHC of PD‐L2 shows low expression (H) and high expression (I). Magnification: ×400. J, All patients were classified into 2 groups: a low PD‐L2 expression group (<1.5, n = 60, blue line) and high PD‐L2 expression group (≥1.5, n = 24, red line). *P < .05 (significant difference). K, Scatter plot comparing the IHC score between ANO9 and PD‐L2 in gastric cancer tissue. An approximately straight line was drawn